- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5517 - 1,4-Benzodiazepines, e.g. diazepam condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
Patent holdings for IPC class A61K 31/5517
Total number of patents in this class: 1201
10-year publication summary
|
80
|
103
|
89
|
104
|
95
|
85
|
92
|
77
|
69
|
46
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MedImmune Limited | 625 |
45 |
| ImmunoGen, Inc. | 401 |
33 |
| F. Hoffmann-La Roche AG | 7944 |
27 |
| The Regents of the University of California | 20211 |
26 |
| Hoffmann-La Roche Inc. | 3511 |
24 |
| PAION UK Limited | 48 |
24 |
| Genentech, Inc. | 4017 |
23 |
| Agenebio, Inc. | 46 |
20 |
| SeaGen Inc | 594 |
19 |
| Council of Scientific & Industrial Research | 1439 |
18 |
| UWM Research Foundation, Inc. | 159 |
18 |
| Dana-Farber Cancer Institute, Inc. | 2613 |
17 |
| The Johns Hopkins University | 5737 |
15 |
| ADC Therapeutics SA | 119 |
15 |
| AbbVie Stemcentrx LLC | 65 |
12 |
| Acura Pharmaceuticals, Inc. | 40 |
11 |
| Oncoethix GmbH | 16 |
11 |
| Ovid Therapeutics Inc | 167 |
11 |
| Centre for Addiction and Mental Health | 141 |
10 |
| Kinoxis Therapeutics Pty Ltd | 18 |
10 |
| Other owners | 812 |